118 related articles for article (PubMed ID: 1703332)
61. Characterization of antibody clones that bind exclusively to insoluble fibrin.
Fuchigami H; Matsumura Y
Blood Coagul Fibrinolysis; 2023 Jan; 34(1):20-27. PubMed ID: 36239546
[TBL] [Abstract][Full Text] [Related]
62. Monoclonal antibodies to fibrinogen-fibrin degradation products which contain D-domain.
Matsumoto T; Nishijima Y; Teramura Y; Fujino K; Hibino M; Hirata M
Thromb Res; 1985 May; 38(3):297-302. PubMed ID: 2410999
[No Abstract] [Full Text] [Related]
63. Human monocytes are associated with the formation of fibrin.
Hogg N
J Exp Med; 1983 Feb; 157(2):473-85. PubMed ID: 6822786
[TBL] [Abstract][Full Text] [Related]
64. Fibrin-Targeting Immunotherapy for Dementia.
Kantor AB; Akassoglou K; Stavenhagen JB
J Prev Alzheimers Dis; 2023; 10(4):647-660. PubMed ID: 37874085
[TBL] [Abstract][Full Text] [Related]
65. Use of synthetic peptides to produce a variety of fibrin antibodies.
McCallion D; Stirk CM; McNally S; Thompson WD; Melvin WT
Biochem Soc Trans; 1996 May; 24(2):285S. PubMed ID: 8736943
[No Abstract] [Full Text] [Related]
66. Flow and antibody binding properties of hydrated fibrins prepared from plasma, platelet rich plasma and whole blood.
Bini A; Callender S; Procyk R; Blombäck B; Kudryk BJ
Thromb Res; 1994 Oct; 76(2):145-56. PubMed ID: 7532325
[TBL] [Abstract][Full Text] [Related]
67. Formation and dissociation of soluble fibrin in vivo.
Mahn I; Schönbach F; Müller-Berghaus G
Thromb Res; 1977 Jul; 11(1):67-80. PubMed ID: 888120
[No Abstract] [Full Text] [Related]
68. Antigenic properties of fibrinogen component of Hemaseel HMN subjected to the antiviral severe dry heat treatment.
Cierniewski CS; Pluskota E; Cieslak M; Brodniewicz T; Nowotarski M
Thromb Res; 1996 May; 82(4):349-59. PubMed ID: 8743730
[TBL] [Abstract][Full Text] [Related]
69. [Fibrinolytic action of an enzyme preparation conjugated with specific antibodies].
Torchilin VP; Maksimenko AV; Ignashenkova GV; Tishchenko EG; Ermolin GA
Biull Eksp Biol Med; 1984 Nov; 98(11):556-8. PubMed ID: 6210119
[TBL] [Abstract][Full Text] [Related]
70. Fibrin polymerisation. Evidence for a secondary polymerisation site on the carboxy terminal end of the AA chain using a human fibrin specific murine monoclonal antibody.
Gaffney PJ; Edgell TA; Walker JM
Ukr Biokhim Zh (1978); 1996; 68(4):43-4. PubMed ID: 9226828
[No Abstract] [Full Text] [Related]
71. Affinity chromatography of soluble fibrin in human plasma on insolubilized fibrinogen and fragment D.
Semeraro N; Collen D
Thromb Res; 1978 Jun; 12(6):1059-70. PubMed ID: 694816
[No Abstract] [Full Text] [Related]
72. Functional molecular anatomy of fibrinogen: antibodies as biological probes of structure.
Edgington TS; Plow EF
Contemp Top Mol Immunol; 1973; 2():237-71. PubMed ID: 4272404
[No Abstract] [Full Text] [Related]
73. Immunochemical analysis of the conformation of fibrinogen.
Plow EF; Edgington TS; Cierniewski CS
Ann N Y Acad Sci; 1983 Jun; 408():44-59. PubMed ID: 6191607
[No Abstract] [Full Text] [Related]
74. Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration.
Ryu JK; Rafalski VA; Meyer-Franke A; Adams RA; Poda SB; Rios Coronado PE; Pedersen LØ; Menon V; Baeten KM; Sikorski SL; Bedard C; Hanspers K; Bardehle S; Mendiola AS; Davalos D; Machado MR; Chan JP; Plastira I; Petersen MA; Pfaff SJ; Ang KK; Hallenbeck KK; Syme C; Hakozaki H; Ellisman MH; Swanson RA; Zamvil SS; Arkin MR; Zorn SH; Pico AR; Mucke L; Freedman SB; Stavenhagen JB; Nelson RB; Akassoglou K
Nat Immunol; 2018 Nov; 19(11):1212-1223. PubMed ID: 30323343
[TBL] [Abstract][Full Text] [Related]
75. Proceedings: Observations on monomolecular layers of fibrinogen at solid-liquid interphases.
Cuypers PA; Hemker HC
Thromb Diath Haemorrh; 1975 Nov; 34(2):555-6. PubMed ID: 1198429
[No Abstract] [Full Text] [Related]
76. Cross-immuno reactivities of mammalian fibrinogens.
Lewis JH
Thromb Res; 1976 Nov; 9(5):473-8. PubMed ID: 63156
[No Abstract] [Full Text] [Related]
77. An immunochemical homology between the Aalpha and a D-E complex-dependent site of the gamma chains of fibrinogen.
Cierniewski C; Plow EF; Edgington TS
J Biol Chem; 1977 Dec; 252(24):8917-23. PubMed ID: 72755
[No Abstract] [Full Text] [Related]
78. Immunoblotting studies of the molecular forms of protein C in plasma.
Heeb MJ; Schwarz HP; White T; Lämmle B; Berrettini M; Griffin JH
Thromb Res; 1988 Oct; 52(1):33-43. PubMed ID: 3201394
[TBL] [Abstract][Full Text] [Related]
79. Comments on "Sensitive immunoassays of nitrated fibrinogen in human biofluids" by Tang et al.
Ponczek MB
Talanta; 2011 Jan; 83(3):1062-3; author reply 1064. PubMed ID: 21147358
[No Abstract] [Full Text] [Related]
80. The measurement of fibrinogenolysis by the quantitation of "soluble" fibrinogen [proceedings].
Wolf P
Biorheology; 1978; 15(1):55-6. PubMed ID: 678630
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
